Research around Human Papillomavirus (HPV), a now well-established cause of cervical cancer, is potentially at a turning point, which could lead to groundbreaking preventative possibilities, cutting down the rate of transmission. Not all people infected with HPV experience symptoms, which is why it’s passed on so easily, and usually not identified early on. The new study, by McGill University’s Division of Cancer Epidemiology, will test a revolutionary way of preventing the transmission of HPV through the use of a topical gel applied during sexual activity. The research team is led by Dr. Eduardo Franco, Director of the Division of Cancer Epidemiology.
The findings from this study indicate that a carrageenan-gel could function as a broad-spectrum topical microbicide targeting sexually transmitted HPVs. “If the upcoming clinical studies are successful, a personal lubricant will both enhance pleasure and provide a protective barrier to HPV transmission,” says Dean Fresonke, CEO of Divine Corporation, the makers of the personal lubricant that was supplied for the McGill University study.
“Positive results from this study would be the start of an entirely new way of approaching cancer prevention,” explained
Franco. “Imagine the impact if women can protect themselves from HPV infection and the risk of cervical cancer through the simple application of a medicinal gel packaged as a personal lubricant.”
“It will be a beautiful way to show how much you care for your partner,” says Fresonke.
Divine 9 is available for purchase at Swor Women’s Care or through our website (www.sworcare.com) on the products page.
